Methylphenidate Stada Arzneimittel Ag (Methylphenidate Hydrochloride)

Methylphenidate works by blocking the reuptake transporters for dopamine and norepinephrine in the brain. This inhibition raises the concentration of these neurotransmitters in the synaptic cleft, enhancing neuronal signaling in pathways that regulate attention, impulse control and arousal, which underlies its therapeutic effects in ADHD and narcolepsy.

The dosage of methylphenidate is individualized. A qualified prescriber determines the appropriate strength, frequency and duration based on the patient’s age, weight, clinical response and tolerability. Dosing may start low and be titrated upward to achieve optimal symptom control while minimizing side effects.

Safety data for methylphenidate in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Both methylphenidate and amphetamine derivatives are central nervous system stimulants used for ADHD, but they differ in pharmacodynamics. Methylphenidate primarily blocks dopamine and norepinephrine reuptake, whereas amphetamines increase release of these neurotransmitters in addition to reuptake inhibition. Clinical response, side‑effect profile and duration of action can vary, so the choice is individualized based on patient characteristics and physician judgment.

Methylphenidate tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister or container, protect from moisture, heat and direct sunlight. Do not store in bathrooms or near kitchen appliances that generate heat.

Methylphenidate is taken orally, usually as a tablet. It may be prescribed for once‑daily or multiple‑daily dosing, depending on the formulation and clinical need. The tablet can be swallowed whole with water, with or without food, as directed by the prescriber. Patients should follow the exact schedule and not exceed the prescribed amount.

Serious risks include cardiovascular complications such as hypertension, tachyarrhythmia or chest pain; psychiatric effects like new or worsening psychosis, severe anxiety or aggression; and rare events such as priapism, seizures or severe allergic reactions. Regular monitoring of blood pressure, heart rate and mental status is essential, especially during treatment initiation and dose adjustments.

Methylphenidate is contraindicated in individuals with known hypersensitivity to the drug, severe cardiovascular disorders (e.g., recent myocardial infarction, uncontrolled hypertension), advanced arteriosclerosis, hyperthyroidism, glaucoma, or a history of drug dependence. Caution is also advised for patients with severe anxiety, tics, or bipolar disorder, and it should be avoided in those taking monoamine oxidase inhibitors.